Determining the optimal follow-up protocol after primary surgery in patients with early-stage endometrial cancer
- Can Ozan Ulusoy 1, Bulut Varlı 2, Ali Gökçe 3, Duygu Altın 4, Şahin Kaan Baydemir 5, Uğur Fırat Ortaç 3, Salih Taşkın 3
- Can Ozan Ulusoy 1, Bulut Varlı 2, Ali Gökçe 3
- 1Clinic of Perinatology, University of Health Sciences Türkiye, Etlik City Hospital, Ankara, Türkiye.
- 2Department of Obstetrics and Gynecology, Ankara University Faculty of Medicine, Ankara, Türkiye.
- 3Department of Gynecologic Oncology, Ankara University Faculty of Medicine, Ankara, Türkiye.
- 4Department of Gynecologic Oncology, Klinikum Bad Salzungen, Thuringia, Germany.
- 5Clinic of Gynecologic Oncology, University of Health Sciences Türkiye, Etlik City Hospital, Ankara, Türkiye.
- 0Clinic of Perinatology, University of Health Sciences Türkiye, Etlik City Hospital, Ankara, Türkiye.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Recurrence risk in early-stage endometrial cancer increases after 25 months, particularly with higher tumor grade and stage. Physical examination and symptoms are key for detecting recurrence, guiding optimal follow-up protocols.
Area Of Science
- Gynecologic Oncology
- Clinical Research
- Cancer Recurrence Studies
Background
- Early-stage endometrial cancer requires effective follow-up strategies to detect recurrence.
- Understanding the timing and risk factors for recurrence is crucial for optimizing patient management.
Purpose Of The Study
- To investigate the timing of recurrence in early-stage endometrial cancer patients.
- To determine the optimal postoperative follow-up protocol for detecting recurrence.
Main Methods
- Analysis of 303 patients with stage 1-2, grade 1-3 endometrioid endometrial cancer.
- Evaluation of diagnostic methods for recurrence detection and risk factor analysis using SPSS.
- Sensitivity analyses comparing diagnostic methods for recurrence.
Main Results
- Recurrence diagnosed in 5.61% of patients; cumulative risk rose to 7.52% by 33 months.
- Increased tumor grade and stage significantly elevated recurrence odds (p=0.033 and p=0.012, respectively).
- Physical examination showed 50% sensitivity and 99.52% specificity for recurrence detection.
Conclusions
- Recurrence risk escalates after 25 months, correlating with higher tumor stage and grade.
- Patient symptoms and physical examination are vital for detecting recurrence, especially after two years.
- Follow-up protocols should consider clinical findings and patient-reported symptoms for timely recurrence detection.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

